BOP Annual Meeting with MSKCC 2025 supporting Band of Parents
BOP Annual Meeting with MSKCC 2025 supporting Band of Parents
About BOP Annual Meeting with MSKCC 2025
You Are Invited
We’re thrilled to invite you to the Band of Parents Annual Meeting with the Memorial Sloan Kettering Cancer Center (MSKCC) Neuroblastoma Team. This special gathering offers a unique opportunity to hear about groundbreaking research, upcoming trials, and ask general questions to the experts leading the fight against neuroblastoma. The session will be led by Dr. Nai-Kong Cheung, Dr. Shakeel Modak and Dr. Brian Kushner.
Prior to the meeting, we’ll host our Annual Hope and Light Awards to honor families, individuals, and extraordinary donors who have championed the cause of pediatric cancer awareness and supported life-saving efforts this past year.
Event Details:
📅 Date: Wednesday, January 29, 2025
⏰ Time: 6:00 PM - 8:00 PM ET
📍 Location:
- In-person: Conference Room M-108, MSKCC, 1275 York Avenue, New York, NY 10065
- Virtual: A live-stream link will be provided following registration.
RSVP by January 15, 2025 to secure your spot.
Attendance is limited to BOP Members. If you would like to become a member, please email kim@bandofparents.org
We hope you’ll join us for this inspiring evening to celebrate progress, recognize contributions, and learn what’s ahead in the fight against neuroblastoma.
Date
Starts at: January 29, 2025 5:00 PM
Ends at: January 29, 2025 7:00 PM
Location
Conference Room M-108
1275 York Avenue
New York,NY 10065 USA
Contact
Priscilla Ma
priscilla@bandofparents.org
How Your Support Makes a Difference
With your support, we can find a cure for neuroblastoma, while reducing the highly toxic nature of treatment. One day, we hope antibodies will replace chemotherapy.
Band of Parents is the top independent backer of neuroblastoma research at Memorial Sloan-Kettering Cancer Center (MSKCC). Our mission is to seek projects that have already been examined in the lab and are in need of assistance to rapidly move into a patient population. In the 1980s, fewer than 5% of children diagnosed with high risk neuroblastoma survived. Although today, most major medical centers like MSKCC have over a 50% survival rate, far too many children are still dying of this disease. The sad fact is that due to the high cost of research and the small number of children diagnosed annually, pediatric cancer is severely underfunded by both the pharmaceutical industry and the federal government. Only 8% of the National Cancer Institute’s funding goes to fight pediatric cancer. We support our members through their children’s battle with neuroblastoma. Together, we are Bound by Hope that a cure is out there. We will continue this fight until not a single child is lost to this disease.